HOTSPOT THERAPEUTICS
HotSpot Therapeutics is a biotech startup that focuses on the development of allosteric therapies targeting regulatory sites on proteins. It develops a therapy platform to discover medicines and provide proper treatment to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases, leverages a database of hotspot structures, harnessing the power of data science in its multidisciplinary approach to drug discovery, and helps patients to get treatment against several diseases. HotSpot Therapeutics was founded in 2017 and is headquartered in Boston, Massachusetts.
HOTSPOT THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Life Science Therapeutics
Founded:
2017-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.hotspotthera.com
Total Employee:
11+
Status:
Active
Contact:
617-758-8998
Email Addresses:
[email protected]
Total Funding:
210 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Amyloid Solution
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Coordination Pharmaceuticals
Coordination Pharmaceuticals is a drug development company that aims to address unmet medical needs and improve patient care.
ERAD Therapeutics
ERAD Therapeutics is a developer of a drug platform designed to create novel biological agents to treat orphan diseases
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Hopewell Therapeutics
Hopewell Therapeutics is a Synthetic Lipid-based drug delivery company for gene therapy and gene editing.
Insitu Biologics
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and proprietary treatments.
Nova Psychotherapy
Nova Psychotherapy is a private practice dedicated to adults looking to start individual psychotherapy.
PhagoMed
PhagoMed is a developer of a biotech platform designed to develop drugs and therapies.
Pipeline Therapeutics
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Relay Therapeutics
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Scioto Biosciences
Scioto is a developer of Activated Bacterial Therapeutics platform.
Scorpion Therapeutics
Scorpion Therapeutics is a precision oncology company that broadens the reach and impact of precision medicine for cancer patients.
Strand Therapeutics
Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.
Tenaya Therapeutics
Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-08-23 | Macroceutics | Macroceutics acquired by HotSpot Therapeutics | N/A |
Investors List
Revelation Partners
Revelation Partners investment in Series C - HotSpot Therapeutics
SR One
SR One investment in Series C - HotSpot Therapeutics
LSP BioVentures
LSP BioVentures investment in Series C - HotSpot Therapeutics
Monashee Investment Management
Monashee Investment Management investment in Series C - HotSpot Therapeutics
Pavilion Capital
Pavilion Capital investment in Series C - HotSpot Therapeutics
B Capital Group
B Capital Group investment in Series C - HotSpot Therapeutics
Atlas Venture
Atlas Venture investment in Series C - HotSpot Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Series C - HotSpot Therapeutics
CaaS Capital Management
CaaS Capital Management investment in Series C - HotSpot Therapeutics
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series C - HotSpot Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-25 | HotSpot Therapeutics Appoints Paul Thibodeau, Ph.D., as Chief Business Officer |
Official Site Inspections
http://www.hotspotthera.com Semrush global rank: 5.11 M Semrush visits lastest month: 1.6 K
- Host name: 104.21.96.31
- IP address: 104.21.96.31
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "HotSpot Therapeutics"
Team - HotSpot Therapeutics
She joins the team from Mersana Therapeutics, where she was the Chief Business Officer and played a major role in transforming the company from an early-stage start-up to a publicly …See details»
Moving Our Core Values Beyond Table Stakes
From our inception in 2016, we wanted to create a very distinctive organization with a clear focus on the “what we are doing” in tandem with “how we do it.” At HotSpot we are really pushing the envelope. The trifecta of our brilliant and …See details»
HotSpot Therapeutics - Crunchbase Company Profile
HotSpot Therapeutics is a biotech startup that focuses on the development of allosteric therapies targeting regulatory sites on proteins. It develops a therapy platform to discover medicines and provide proper treatment to identify …See details»
HotSpot Therapeutics, Inc. | LinkedIn
HotSpot Therapeutics, Inc. | 4,261 followers on LinkedIn. Inspired by nature’s ability to regulate protein function to restore health, HotSpot Therapeutics is discovering new allosteric ...See details»
HotSpot Therapeutics, Inc. Management Team | Org Chart
HotSpot Therapeutics, Inc. employs 76 employees. The HotSpot Therapeutics, Inc. management team includes Jonathan Montagu (President and Chief Executive Officer), Geraldine Harriman …See details»
HotSpot Therapeutics - eqtgroup.com
HotSpot Therapeutics, Inc. is a biotechnology company pioneering the discovery and development of small molecule allosteric therapies targeting regulatory sites on proteins referred to as “natural hotspots"See details»
HotSpot Therapeutics CEO and Key Executive Team | Craft.co
HotSpot Therapeutics's Vice President, Biology is Michael Tota. Other executives include Jonathan Montagu, Co-Founder and Chief Executive Officer, Director; Geraldine Harriman, Co …See details»
HotSpot Therapeutics - Overview, News & Similar companies
Dec 12, 2022 HotSpot Therapeutics contact info: Phone number: (617) 758-8998 Website: www.hotspotthera.com What does HotSpot Therapeutics do? HotSpot Therapeutics is …See details»
Careers - HotSpot Therapeutics
We are building a company where values (or purpose) drive everything we do inside and outside the organization. We need rebellious innovation to reject the status quo, try new ideas, and have the confidence to challenge conventional …See details»
HotSpot Therapeutics - Work in biotech
Founded: 2017 Location: Boston, MA Employee range: 11 - 50 Clinical stage: Clin1/Clin2 Therapy area: Advanced solid tumors Drug types: IMM, ONC, RHU, MUS Lead product: HST-1011 …See details»
Working At Hotspot Therapeutics: Company Overview and Culture …
Www.hotspotthera.com. Organization Type. Private. Social Media. Hotspot Therapeutics derives medical solutions from natural solutions. Hotspot Therapeutics is a small pharmaceutical …See details»
GOSTAR® & HotSpot Therapeutics' AI for Allosteric Drug …
May 25, 2022 Hyderabad, India and Boston, U.S.A., (May 25, 2022): Excelra, a leading global data, and digital insights organization, today announced a partnership with HotSpot …See details»
Excelra Partners with HotSpot Therapeutics to Enhance ... - Newswire
May 25, 2022 HYDERABAD, India and BOSTON, May 25, 2022 /CNW/ -- Excelra, a leading global data and digital insights organization, today announced a partnership with HotSpot …See details»
HotSpot Therapeutics (UK) Funding: $5.5M - Medical Startups
Nov 7, 2024 Inspired by nature’s ability to regulate protein function to restore health, HotSpot Therapeutics is discovering new allosteric therapies with the ability to treat disease in new …See details»
AbbVie Launches Strategic Collaboration with HotSpot …
Dec 6, 2022 To learn more, visit www.hotspotthera.com. Forward-Looking Statements. Some statements in this news release are, or may be considered, forward-looking statements for …See details»
HotSpot Therapeutics · GitHub
Unlocking nature's regulatory mechanisms to advance allosteric drug discovery - HotSpot TherapeuticsSee details»
HotSpot Therapeutics Appoints Eva Jack as Chief Operating Officer
HotSpot’s lead compounds include the first and only allosteric inhibitors to target PKC-theta for autoimmune diseases and S6 kinase, a critical signaling node involved in the regulation of …See details»
HotSpot Therapeutics Presents Preclinical Data from MALT1 CBM ...
BOSTON, Oct. 23, 2024 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, small molecule allosteric therapies targeting …See details»
HotSpot Therapeutics Presents Additional Phase 1 Biomarker Data …
Nov 7, 2024 Leveraging this approach, HotSpot is building a broad pipeline of novel allosteric therapies for the treatment of cancer and autoimmune diseases. To learn more, visit …See details»